British Journal of Clinical Pharmacology

Sorivudine and 5-fluorouracil; a clinically significant drug-drug interaction due to inhibition of dihydropyrimidine dehydrogenase
pp. 1-4(4)
Author: Diasio R.B.

Pharmacokinetics of recombinant human interleukin-2 in advanced renal cell carcinoma patients following subcutaneous application
pp. 5-10(6)
Authors: Kirchner G.I.; Franzke A.; Buer J.; Beil W.; Probst-Kepper M.; Wittke F.; Övermann K.; Lassmann S.; Hoffmann R.; Kirchner H.; Ganser A.; Atzpodien J.

Pharmacokinetic analysis of subcutaneous erythropoietin administration with nonlinear mixed effect model including endogenous production
pp. 11-19(9)
Authors: Hayashi N.; Kinoshita H.; Yukawa E.; Higuchi S.

Single dose pharmacokinetics of lamivudine in subjects with impaired renal function and the effect of haemodialysis
pp. 21-27(7)
Authors: Johnson M.A.; Verpooten G.A.; Daniel M.J.; Plumb R.; Moss J.; Van Caesbroeck D.; De Broe M.E.

Topical penetration of commercial salicylate esters and salts using human isolated skin and clinical microdialysis studies
pp. 29-35(7)
Authors: Cross S.E.; Anderson C.; Roberts M.S.

Pulmonary administration of aerosolised fentanyl: pharmacokinetic analysis of systemic delivery
pp. 37-43(7)
Authors: Mather L.E.; Woodhouse A.; Ward M.E.; Farr S.J.; Rubsamen R.A.; Eltherington L.G.

Early lung absorption profile of non-CFC salbutamol via small and large volume plastic spacer devices
pp. 45-48(4)
Authors: Lipworth B.J.; Clark D.J.

Different effects of itraconazole on the pharmacokinetics of fluvastatin and lovastatin
pp. 49-53(5)
Authors: Kivistö K.T.; Kantola T.; Neuvonen P.J.

Involvement of CYP1A2 in mexiletine metabolism
pp. 55-62(8)
Authors: Nakajima M.; Kobayashi K.; Shimada N.; Tokudome S.; Yamamoto T.; Kuroiwa Y.

Perindopril postmarketing surveillance: a 12 month study in 47 351 hypertensive patients
pp. 63-70(8)
Authors: Speirs C.; Wagniart F.; Poggi L.

Risk factors for mortality in users of ibopamine
pp. 71-77(7)
Authors: Feenstra J.; int Veld B.A.; van der Linden P.D.; Grobbee D.E.; Stricker B.H.C.

Adverse effects of a single dose of (+)-sotalol in patients with mild stable asthma
pp. 79-82(4)
Authors: Devereux G.; Fishwick K.; Aiken T.C.; Bourke S.J.; Hendrick D.J.

Effect of food and gender on the pharmacokinetics of tucaresol in healthy volunteers
pp. 83-86(4)
Authors: Peck R.W.; Wootton R.; Wiggs R.; Layton G.; Posner J.